No abstract

Background A magnetic resonance image (MRI) guided robotic device for focussed ultrasound therapy of prostate cancer (PC) was developed. The device offers movement in 5 degrees of freedom (DOF) and uses a single‐element transducer that operates at 3.2 MHz, has a diameter of 25 mm and focuses at 45 mm. Methods The MRI compatibility of the system was evaluated in a 1.5 T scanner. The ability of the transducer to create lesions was evaluated in laboratory and MRI settings, on ex vivo pork tissue and in vivo rabbit thigh tissue. Results Cavitational and thermal lesions were created on the excised pork tissue. In vivo experiments proved the efficacy of the system in ablating muscle tissue without damaging intervening areas. Conclusions The MRI compatible robotic system can be placed on the table of any commercial MRI scanner up to 7 T. The device has the ability of future use for transrectal focal therapy of PC with the patient in supine position.

No abstract

No abstract

BackgroundHerein, a robotic system offering Magnetic Resonance‐guided Focused Ultrasound (MRgFUS) therapy of thyroid nodules was developed.MethodsThe robotic system offers linear motion in 2 PC‐controlled axes that navigate a 3 MHz single‐element focused transducer. The system, through a C‐arm structure attaches to the table of Magnetic Resonance Imaging (MRI) scanners and couples to the neck of patients lying in the supine position. The MRI compatibility of the developed system was assessed inside a 3 T scanner. Benchtop and MRI feasibility studies evaluating the heating performance of the system were executed on excised pork tissue and on homogeneous and thyroid model agar‐based phantoms.ResultsThe MRI compatibility of the system was successfully established. Grid sonications executed using robotic motion inflicted discrete and overlapping lesions on the excised tissue, while magnetic resonance (MR) thermometry successfully monitored thermal heating in agar‐based phantoms.ConclusionsThe developed system was found to be efficient with ex‐vivo evaluation. The system can perform clinical MRgFUS therapy of thyroid nodules and other shallow targets after further in‐vivo evaluation.